PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

norepinephrine Side Effects

The reactions most often reported to the FDA for norepinephrine (also sold as Levophed), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

10,232
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of norepinephrine come from 10,232 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 10,232 reports to the FDA Adverse Event Reporting System (FAERS) for norepinephrine (Levophed): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

10,232

Reports Mentioning Death

3,288

32.1% of reports — not proof the medicine caused the death

Hospitalizations

5,663

55.3% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

HYPOTENSION
1,011
ACUTE KIDNEY INJURY
747
MULTIPLE ORGAN DYSFUNCTION SYNDROME
652
TOXICITY TO VARIOUS AGENTS
624
CONDITION AGGRAVATED
560
SEPSIS
537
CARDIAC ARREST
533
CARDIOGENIC SHOCK
503
SEPTIC SHOCK
438
RESPIRATORY FAILURE
375
SHOCK
374
METABOLIC ACIDOSIS
346
INTENTIONAL OVERDOSE
327
DRUG INTERACTION
325
VOMITING
325
PNEUMONIA
316
DEATH
312

Who Reports Side Effects

Gender Distribution

Female 4,177 (45%)
Male 5,189 (55%)
Unknown 15

Age Distribution

0-17 794 (9%)
18-44 2,054 (23%)
45-64 2,959 (33%)
65-74 1,804 (20%)
75+ 1,343 (15%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 3,288 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME 565
SEPSIS 428
HYPOTENSION 344
CARDIAC ARREST 312
DEATH 312
CONDITION AGGRAVATED 305
ACUTE KIDNEY INJURY 300
SEPTIC SHOCK 274
CARDIOGENIC SHOCK 269
TOXICITY TO VARIOUS AGENTS 264
GENERAL PHYSICAL HEALTH DETERIORATION 244
VOMITING 244
ABDOMINAL PAIN 240
ASCITES 230
NAUSEA 229
ABDOMINAL DISTENSION 226
HYPONATRAEMIA 214
APPENDICITIS 210

Reactions in Hospitalization Reports

Top reactions in 5,663 reports where hospitalization was an outcome.

Reaction Reports
HYPOTENSION 714
TOXICITY TO VARIOUS AGENTS 519
ACUTE KIDNEY INJURY 489
MULTIPLE ORGAN DYSFUNCTION SYNDROME 388
CONDITION AGGRAVATED 357
CARDIOGENIC SHOCK 339
CARDIAC ARREST 327
INTENTIONAL OVERDOSE 318
SEPSIS 304
SEPTIC SHOCK 284
DRUG INTERACTION 263
LACTIC ACIDOSIS 260
SHOCK 255
OVERDOSE 249
PNEUMONIA 244
RESPIRATORY FAILURE 239
METABOLIC ACIDOSIS 236
BRADYCARDIA 210

Compare norepinephrine vs adenosine →

What the FAERS Data Reveals About norepinephrine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 10,232 voluntary reports linked to norepinephrine and its brand equivalents (Levophed), spanning 2004 through 2025. Of those, 3,288 (32.1%) listed death as an outcome and 5,663 (55.3%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 45% were female and 55% male; age distribution skews toward 45-64, with 2,959 reports in that bracket. The single most reported reaction is hypotension with 1,011 submissions, followed by acute kidney injury and multiple organ dysfunction syndrome.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.

Drugs With a Similar FAERS Report Volume

Other medications with a total FDA adverse-event report count closest to norepinephrine's 10,232.